Cargando…
Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion
High infection caused by mutations of SARS-CoV-2 calls for new prevention strategy. Ganoderma lucidum known as a superior immunoenhancer exhibits various antiviral effects, whether it can resist SARS-CoV-2 remains unclear. Herein, virtual screening combined with in vitro hACE2 inhibition assays were...
Autores principales: | Xu, Juan, Yang, WenTao, Pan, YiFeng, Xu, HaiShun, He, Liang, Zheng, BingSong, Xie, YingQiu, Wu, XueQian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526994/ https://www.ncbi.nlm.nih.gov/pubmed/36179993 http://dx.doi.org/10.1016/j.fct.2022.113438 |
Ejemplares similares
-
A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids
por: Zheng, Chengwen, et al.
Publicado: (2023) -
Prediction of infectivity of SARS-CoV-2 virus based on Spike-hACE-2 interaction
por: Chaudhuri, Dwaipayan, et al.
Publicado: (2022) -
The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
por: Xie, Yixin, et al.
Publicado: (2021) -
The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
por: Xie, Yixin, et al.
Publicado: (2022) -
Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening
por: Hu, Xiaopeng, et al.
Publicado: (2022)